Xcout Intel
Nanordica Medical
Nanordica Medical is an Estonian medtech company founded in 2019 and headquartered in Tallinn, dedicated to developing first-in-class wound care products based on nanotechnology.
Subscribe to see Nanordica Medical’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Nanordica Medical at a glance
Nanordica Medical is a medical supplies company headquartered in Estonia. It has raised at least $3.4M across the 2 funding rounds on record. Its most recent funding round, Seed, raised $1.6M in June 2026. Xcout tracks 5 named people at Nanordica Medical, including Olesja Bondarenko (Chief Executive Officer PhD).
Nanordica Medical leadership
- Olesja BondarenkoChief Executive Officer PhD
- Viktor MahhovChief Financial Officer
- Andres ValknaChief Technology Officer
- Grigory VasilievChief Clinical Officer PhD, MD
- Meelis KadajaChief Business Officer PhD, MBA
Nanordica Medical funding rounds
At least $3.4M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $1.6M | 6 named | |
| Seed | $1.8M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Nanordica Medical competitors
A few of Nanordica Medical's closest competitors — see the full list of competitors and alternatives →
TYBR Health, Inc. is a medical device and regenerative medicine company founded in 2020 that specializes in developing products to improve post-operative surgical recovery.
MedVital (MedVital Ventures Private Limited) is a medical technology company based in India. It focuses on developing innovative products and technologies for wound care, wound closure, tissue regeneration, and scar management.
Amferia is a Swedish biotechnology company specializing in antimicrobial wound-care solutions using bio-inspired peptides. Founded in Gothenburg, the company operates a clinical production site in Mölndal for testing and evaluating its healthcare products.
S2Medical AB is a Swedish biomed-tech company that develops products and technologies for wound healing, infection control, and cosmeceuticals. The company utilizes biomaterials, regenerative medicine, and antimicrobial peptides to create solutions such as negative pressure therapy systems and treatments for multi-resistant bacterial infections, serving patients and healthcare providers.
SolasCure Limited is a biotechnology research company registered and headquartered in Cambridge, United Kingdom, focused on developing novel wound care solutions.
Nowound, developed by the medical technology startup Medvital, is a Gurugram-based seed company founded in 2024 that specializes in advanced wound care. It offers a digitally enabled negative pressure wound therapy device designed to enhance wound closure, reduce infection risk, and support tissue regeneration.
Get Nanordica Medical's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Nanordica Medical? Suggest a correction · Work at Nanordica Medical? Claim this profile
Is this your company? Add the Xcout Intel badge to your website
Free, for any company on Xcout Intel. It links visitors to this profile.
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Nanordica Medical in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access